Iovance Biotherapeutics
IOVA
IOVA
81 hedge funds and large institutions have $361M invested in Iovance Biotherapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 87 → 81 (-6)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
81
Holding in Top 10
3
Calls
$1.19M
Puts
$139K
Top Buyers
| 1 | +$45.2M | |
| 2 | +$1.68M | |
| 3 | +$1.48M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.47M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
Top Sellers
| 1 | -$4.7M | |
| 2 | -$2.94M | |
| 3 | -$1.24M | |
| 4 |
First Eagle Investment Management
New York
|
-$1.04M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.03M |